Pacific Biosciences of California, Inc. (PACB) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Pacific Biosciences of California, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.03x | -1.62x | -8.11x | -5.85x | -22.99x | 145.73x |
| P/B Ratio | 104.87x | 0.99x | 3.55x | 3.26x | 5.27x | 12.77x |
| P/S Ratio | 3.51x | 3.26x | 12.41x | 14.32x | 31.92x | 54.31x |
| Profitability | ||||||
| Gross Margin | 31.7% | 24.2% | 26.3% | 38.2% | 45.1% | 41.3% |
| Operating Margin | -348.5% | -308.0% | -166.8% | -239.4% | -161.2% | -132.3% |
| Net Margin | -341.5% | -201.2% | -153.0% | -244.9% | -138.9% | 37.3% |
| EBITDA Margin | -21.4% | -157.6% | -135.2% | -220.0% | -192.1% | 49.4% |
| Liquidity | ||||||
| Current Ratio | 6.89x | 7.48x | 7.81x | 3.24x | 15.36x | 9.24x |
| Quick Ratio | 5.99x | 6.59x | 7.21x | 3.04x | 15.01x | 8.87x |
| Leverage | ||||||
| Debt/Equity | 141.98x | 1.33x | 1.33x | 1.68x | 1.21x | 0.13x |
YoY = year-over-year change. Source: FMP..